CRE-319-M2

N/A

Report date: 2022/02/17 17:10:32
NME

Base Information

Drug NameCRE-319-M2
Drug Alias NameCRE-319-M2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersSodium channel alpha subunit blockers
TargetsPotassium channelSodium channel alpha subunit
Therapy Area/IndicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCermol
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCermol
Active IndicationsN/A
Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A